A Randomised Comparison of Short and Protracted Neoadjuvant Hormonal Therapy Prior to Radiation Therapy of High Risk Localized Prostate Cancer.

Trial Profile

A Randomised Comparison of Short and Protracted Neoadjuvant Hormonal Therapy Prior to Radiation Therapy of High Risk Localized Prostate Cancer.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2016

At a glance

  • Drugs Flutamide (Primary) ; Triptorelin (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Dec 2011 Additional trial centre identified, inclusion and exclusion criteria amended as reported by ClinicalTrials.gov.
    • 13 Dec 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 13 Dec 2011 Official Title amended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top